Congenital CMV Treatment — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Oral valganciclovir for 6 months
Symptomatic congenital CMV (CNS involvement, hearing loss) should be treated with oral valganciclovir for 6 months. This improves hearing and developmental outcomes. Treatment should be commenced within the first month of life for best outcomes.
Reference: RCH Melbourne – 2024 – Clinical Practice Guidelines: Congenital CMV